Letter to the editor: A revised electronic version of RUCAM for the diagnosis of drug‐induced liver injury
Harshad Devarbhavi, Sunu Sara Kurien – 20 April 2022
Neutralization and receptor use of infectious culture–derived rat hepacivirus as a model for HCV
Raphael Wolfisberg, Caroline E. Thorselius, Eduardo Salinas, Elizabeth Elrod, Sheetal Trivedi, Louise Nielsen, Ulrik Fahnøe, Amit Kapoor, Arash Grakoui, Charles M. Rice, Jens Bukh, Kenn Holmbeck, Troels K. H. Scheel – 20 April 2022
Identification of the chloride channel, leucine‐rich repeat‐containing protein 8, subfamily a (LRRC8A), in mouse cholangiocytes
Nikolay Shcheynikov, Kristy Boggs, Anthony Green, Andrew P. Feranchak – 20 April 2022
First‐line therapies for hepatitis B in the United States: A 3‐year prospective and multicenter real‐world study after approval of tenofovir alefenamide
Calvin Q. Pan, Nezam H. Afdhal, Victor Ankoma‐Sey, Ho Bae, Michael P. Curry, Douglas Dieterich, Lynn Frazier, Andrew Frick, Hie‐Won Hann, W. Ray Kim, Paul Kwo, Scott Milligan, Myron J. Tong, K. Rajender Reddy – 20 April 2022 – Real‐world data are limited on tenofovir alafenamide (TAF). We aimed to study TAF real‐world outcomes with other first‐line regimens for chronic hepatitis B (CHB). We enrolled patients with CHB from 10 centers retrospectively and followed them for 36 months prospectively.
CAQ Corner: Long‐term medical complications of liver transplantation
Monica Tincopa – 20 April 2022
Relationship between NAFLD and coronary artery disease: A Mendelian randomization study
Zhewen Ren, Pomme I. H. G. Simons, Anke Wesselius, Coen D. A. Stehouwer, Martijn C. G. J. Brouwers – 19 April 2022
Diagnosis and Treatment of Wilson Disease
Wilson disease (WD; also known as hepatolenticular degeneration) was first described in 1912 by Kinnear Wilson as “progressive lenticular degeneration,” a familial, lethal neurological disease accompanied by chronic liver disease leading to cirrhosis.
Vascular Liver Disorders
Previous guidelines reviewing vascular disorders of the liver focused on thrombosis of large vessels, such as the portal vein (PV) and hepatic vein (HV)
Transjugular Intrahepatic Portosystemic Shunt (TIPS)
Transjugular Intrahepatic Portosystemic Shunt (TIPS) has been in use for more than 20 years to treat the complications of portal hypertension and TIPS have been created in thousands of patients with liver disease worldwide.
Reproductive Health and Liver Disease
This first Practice Guidance on Reproductive Health from AASLD is intended to be a comprehensive reference on adolescents and adults with chronic liver disease.